Income Taxes (Tables)
|
12 Months Ended |
Dec. 31, 2023 |
| Income Tax Disclosure [Abstract] |
|
| Schedule of Income before Income Tax, Domestic and Foreign |
and Income tax expense (benefit) consisted of the following: | | | | | | | | | | | | | | | | | | | Year Ended December 31, | | 2023 | | 2022 | | 2021 | | (In thousands) | | Income (loss) from continuing operations before income taxes: | | | | | | | Domestic operations | $ | (114,700) | | | $ | 8,826 | | | $ | (129,903) | | | Foreign operations | 47,572 | | | (10,895) | | | 8,122 | | | $ | (67,128) | | | $ | (2,069) | | | $ | (121,781) | | | Income tax expense (benefit): | | | | | | | Current: | | | | | | | Federal | $ | 949 | | | $ | 3,780 | | | $ | — | | | State | 4,177 | | | 4,957 | | | 829 | | | Foreign | 8,997 | | | 3,405 | | | 9,862 | | | 14,123 | | | 12,142 | | | 10,691 | | | Deferred: | | | | | | | Domestic operations | (22,866) | | | 73,370 | | | (29,801) | | | Foreign operations | (4,546) | | | (49,392) | | | (418) | | | (27,412) | | | 23,978 | | | (30,219) | | | $ | (13,289) | | | $ | 36,120 | | | $ | (19,528) | |
|
| Schedule of Effective Income Tax Rate Reconciliation |
The Company’s Income tax expense (benefit) from continuing operations differs from the amount that would be computed by applying the U.S. federal statutory rate as follows: | | | | | | | | | | | | | | | | | | | Year Ended December 31, | | 2023 | | 2022 | | 2021 | | (In thousands) | | Taxes calculated at the U.S. federal statutory rate | $ | (14,097) | | | $ | (435) | | | $ | (25,574) | | | State taxes | (1,835) | | | 10,878 | | | (4,473) | | | Effect of tax rates on international operations | (3,053) | | | (5,106) | | | 681 | | | | | | | | | Changes in valuation allowance | 4,646 | | | (12,126) | | | (4,496) | | | Changes in tax reserves | (2,182) | | | 1,724 | | | (2,332) | | | | | | | | | | | | | | | | | | | | | Research and development tax credits | (4,499) | | | (2,599) | | | (2,392) | | | | | | | | | Net items not deductible (taxable) | (1,478) | | | 1,859 | | | 772 | | | U.S. tax on international operations | 2,789 | | | 4,565 | | | 14,865 | | | Transaction related costs | 840 | | | 27,699 | | | — | | | | | | | | | Non-deductible employee compensation | 5,232 | | | 9,013 | | | 2,562 | | | | | | | | | Other | 348 | | | 648 | | | 859 | | | Income tax expense (benefit) | $ | (13,289) | | | $ | 36,120 | | | $ | (19,528) | |
|
| Schedule of Deferred Tax Assets and Liabilities |
The significant components of deferred tax assets and liabilities included in continuing operations are as follows: | | | | | | | | | | | | | December 31, | | 2023 | | 2022 | | (In thousands) | | Deferred tax assets: | | | | | Expenses currently not deductible | $ | 30,787 | | | $ | 30,428 | | | Net operating loss and interest expense limitation carryforward | 119,247 | | | 162,713 | | | Tax credit carryforward | 37,358 | | | 37,883 | | | Depreciation and amortization | 57,901 | | | 28,659 | | | Inventory reserves and capitalization | 18,585 | | | 6,731 | | | Capitalized R&D expenditures | 41,343 | | | 29,579 | | | Non-current lease liability | 17,798 | | | 17,815 | | | Other | 6,069 | | | 2,171 | | | Valuation allowance | (101,650) | | | (93,542) | | | Deferred tax assets, net | 227,438 | | | 222,437 | | | Deferred tax liabilities: | | | | | Depreciation and amortization | (226,802) | | | (237,374) | | | | | | | | | | | Lease asset - right of use | (16,463) | | | (17,380) | | | Total deferred tax liabilities | (243,265) | | | (254,754) | | | Total deferred tax liabilities, net | $ | (15,827) | | | $ | (32,317) | |
|
| Summary of Income Tax Contingencies |
The Company records a liability for unrecognized income tax benefits for the amount of benefit included in its previously filed income tax returns and in its financial results expected to be included in income tax returns to be filed for periods through the date of its Consolidated Financial Statements for income tax positions for which it is not more likely than not to be sustained upon examination by the respective taxing authority. A reconciliation of the beginning and ending amount of gross unrecognized tax benefits is as follows: | | | | | | | (In thousands) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Balance, January 1, 2021 | $ | 58,014 | | | Acquisitions and divestitures | 4,450 | | | Addition for tax positions taken in prior periods | 228 | | | Addition for tax positions taken in the current period | 3,653 | | | Reductions related to settlements with taxing authorities | (425) | | | Reductions resulting from a lapse of applicable statute of limitations | (3,239) | | | Other, including the impact of foreign currency translation | (734) | | | Balance, December 31, 2021 | 61,947 | | | Acquisitions and divestitures | (23,250) | | | | | Addition for tax positions taken in the current period | 462 | | | | | Reductions resulting from a lapse of applicable statute of limitations | (244) | | | Other, including the impact of foreign currency translation | (616) | | | Balance, December 31, 2022 | 38,299 | | | Acquisitions and divestitures | 2,052 | | | Addition for tax positions taken in prior periods | 3,659 | | | Addition for tax positions taken in the current period | 2,251 | | | Reductions related to settlements with taxing authorities | (125) | | | Reductions resulting from a lapse of applicable statute of limitations | (14,240) | | | Other, including the impact of foreign currency translation | 230 | | | Balance, December 31, 2023 | $ | 32,126 | |
|